Safeguard Scientifics (NYSE:SFE) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Safeguard Scientifics (NYSE:SFEGet Rating) in a research report released on Monday. The firm issued a hold rating on the asset manager’s stock.

Safeguard Scientifics Price Performance

SFE stock opened at $3.34 on Monday. Safeguard Scientifics has a 1-year low of $3.19 and a 1-year high of $7.74. The business has a 50-day moving average price of $3.62 and a 200 day moving average price of $3.84. The company has a market capitalization of $54.51 million, a P/E ratio of -3.12 and a beta of 0.99.

Institutional Investors Weigh In On Safeguard Scientifics

Several hedge funds have recently modified their holdings of SFE. State Street Corp boosted its position in Safeguard Scientifics by 17.2% during the second quarter. State Street Corp now owns 21,165 shares of the asset manager’s stock valued at $79,000 after purchasing an additional 3,111 shares in the last quarter. Shufro Rose & Co. LLC purchased a new position in shares of Safeguard Scientifics in the 1st quarter worth approximately $174,000. Legal & General Group Plc raised its stake in shares of Safeguard Scientifics by 5.3% during the 2nd quarter. Legal & General Group Plc now owns 95,711 shares of the asset manager’s stock worth $357,000 after acquiring an additional 4,815 shares in the last quarter. EJF Capital LLC boosted its stake in Safeguard Scientifics by 5.6% in the first quarter. EJF Capital LLC now owns 172,955 shares of the asset manager’s stock valued at $903,000 after acquiring an additional 9,151 shares in the last quarter. Finally, Clayton Partners LLC grew its holdings in Safeguard Scientifics by 21.3% in the first quarter. Clayton Partners LLC now owns 297,066 shares of the asset manager’s stock worth $1,551,000 after purchasing an additional 52,172 shares during the last quarter. Hedge funds and other institutional investors own 62.03% of the company’s stock.

Safeguard Scientifics Company Profile

(Get Rating)

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Featured Articles

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.